Boosting your testosterone may boost your free-trending testosterone, according to new research.
In a study published in the journal Nature Medicine, researchers at the University of California, Berkeley found that a high dose of testosterone can increase your testosterone to within 0.4% of baseline.
This would be enough to raise your free and average testosterone levels to within 10 to 15% of your baseline levels.
In other words, the researchers found that increasing your free free testosterone level to between 1.2% and 2.2%, or around 1.5 to 2% of the baseline levels, could increase your potential testosterone levels by up to 5 to 15%.
This would mean that if you were in your mid-30s, and your free baseline testosterone level was 1.1%, you could increase that number to 2.1% in just five to 15 minutes.
“Our findings indicate that a small dose of oral testosterone can significantly increase free testosterone and increase testosterone sustanon (testosterone levels), which is not seen with an injection,” lead author Dr. Rong Zhao, a doctoral candidate in the Department of Biology and Biomedical Engineering at UC Berkeley, said in a statement.
According to Zhao, these findings could help explain the positive effect that testosterone injections have on testosterone levels in healthy men.
“In men with normal levels, testosterone is converted to estradiol by the liver and then stored in the liver for use in the body,” Zhao said.
“In our study, however, the free testosterone concentration did not change in the same way in healthy participants who were taking testosterone injections.
Thus, testosterone injections do not increase estradol production in healthy males.”
The study involved over 100 healthy men, who were randomly assigned to take either a placebo (the same as taking a placebo) or a high-dose testosterone (500 mg/day).
After four weeks of taking the high-towards-2.2 mg dose, participants who had a free testosterone of at least 2.5% were tested.
The test subjects also completed a physical test and completed a questionnaire.
Participants who took the high dose had a higher free testosterone than those who took a placebo.
The free testosterone difference was statistically significant after four weeks, with a P value of 0.0001.
After eight weeks of the testosterone dose, the subjects had higher free-TEST scores than the placebo group, with the higher free test scores suggesting that the higher dose of the high testosterone helped them to improve their free testosterone.
However, the increase in free testosterone was not observed after eight weeks.
This suggests that the testosterone boost was a transient effect.
The authors note that the current study, which used a placebo and placebo-containing testosterone solution, has limitations, including a small sample size, a small number of participants and the fact that the high doses were administered over a long period of time.
While the study has not yet been published, Zhao and his colleagues believe that their findings could provide insight into the effects of testosterone therapy on muscle and bone.
“If the findings can be replicated in larger studies, it could lead to a broader evaluation of the potential benefits of testosterone and other hormone therapies,” Zhao concluded.